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Alginates are classed as a dietary fibre and have been shown to inhibit digestive enzymes in vitro, and
therefore could be used as an obesity treatment. The current study aims to assess whether alginate in a
bread vehicle maintains its inhibition properties despite cooking and digestion, and may therefore be
used as a potential treatment for obesity. After 180 min in a model gut that replicates digestion in the
mouth, stomach and small intestines alginate bread (AB), control bread (CB), CB with Manucol® DM
alginate, free DM alginate and model gut solution were collected. DM, LFR 5/60 and SF200 were heated at
37 C and 200 C, with DM also heated at 50, 100 and 150 C. Samples from the model gut and heated
alginate were assessed for molecular size and inhibition properties using viscosity, gel filtration and a
lipase turbidity assay. AB does not significantly increase viscosity in the model gut. Viscosity of alginate
reduces beyond 100 C, although alginate retains its inhibition properties up to 150 C. Cooking into the
bread does not reduce the molecular size of the alginate or affect its inhibition properties. These data
demonstrate the robustness of alginates lipase inhibition despite the cooking process and digestion.
Therefore adding alginate to a bread vehicle may have the potential in the treatment for obesity.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The World Health Organisation (WHO) recognised obesity as a
global epidemic in 1997, and predict that the number of peoplewho
are obese and overweight is set to continue to rise (FAO/WHO,
2003). Although the most recognised form of maintaining a
healthy weight is to consume a healthy diet and exercise, this is
rarely achieved with adherence rates as low as 15% (Ayyad &
Andersen, 2000). Alternative weight loss treatments such as
pharmaceutical agents and surgery are available, however these
treatments are associated with side effects and are not cost effec-
tive (Finer, James, Kopelman, Lean, & Williams, 2000; Hadvary,
Lengsfeld, & Wolfer, 1988; Pi-Sunyer, 2006; Rich, Rubin, Walker,
Schneeweiss, & Abenhaim, 2000).GI, gastrointestinal tract; MO,
CB, control bread.
ughton).
r Ltd. This is an open access articlAn alternative treatment which has received considerable in-
terest is dietary fibre, specifically alginate as a potential weight loss
treatment (Strugala, Kennington, Campbell, Skjak-Braek, & Dett-
mar, 2005; Sunderland, Dettmar, & Pearson, 2000; Wilcox,
Brownlee, Richardson, Dettmar, & Pearson, 2014). Alginates are
present as a matrix polysaccharide in the cell walls of brown algae
and consist of (Grasdalen, Larsen, & Smidsrod, 1977). These resi-
dues can combine to form G rich (G blocks), M rich (M blocks) or a
mixture of G and M. The pattern of residues determines the phys-
icochemical properties of alginate. They are widely used in in-
dustry, including adding to foods or beverages as thickening and
stabilising agents as reviewed by Brownlee et al. (2005). An addi-
tional benefit of alginate is that it is able to form both ionic and
acidic gels. This may be a possible mechanism for a reduction in the
digestibility of macronutrients and a reduction in hunger seen after
consumption of alginates in mixed diets partially because of the
viscosity increase caused by gel formation in the stomach at low pH
(Draget, Skjåk Bræka,& Stokke, 2005; Ellis, Apling, Leeds,& Bolster,
1981; Seal & Mathers, 2001; Wolf et al., 2002).e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Greggs Plc bread ingredients with or without Manucol® DM alginate at 4% per 100 g.
Regular bread BF0003-5
Nutrients per 100 g
Energy (kcal) 247
Energy (kJ) 1046
Protein (g) 10.2
Carbohydrates (g) 46.2
Sugars 1.1
Starch 45
Fat (g) 1.7
Saturates 0.5
Monosaturates 0.3
Polyunsaturates 0.6
Trans 0
Dietary fibre (AOAC) (g) 3
Sodium (g) 0.4 (374 mg)
Water (g) 36.8
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treatment added it to a beverage or cereal bar. The benefits re-
ported in these studies include increased satiety, reduced calories
consumed, reduced blood glucose and insulin, reduced fat diges-
tion and weight loss. These beneficial physiological effects are
countered by a number of problems including poor palatability,
products being returned, burping, nausea, flatulence, stomach ache
and subjects preferring the control products (Georg Jensen,
Kristensen, & Astrup, 2012; Sandberg et al., 1994; Torsdottir,
Alpsten, Holm, Sandberg, & Tolli, 1991; Williams et al., 2004).
Poor palatability of these products may be due to gel formation and
a slimy mouth feel (Ellis et al., 1981). The current study developed
alginate-enriched bread in an attempt to overcome these adverse
side effects, although the cooking process where temperatures may
exceed 180 C (Hasatani et al., 1991) may alter alginate properties,
and in doing so reduce the ability of the alginate to alter the
digestion process and inhibit digestive enzymes in the upper
gastrointestinal tract (GI).
There are limited data on the properties of the alginate once it
has been exposed to heat above 37 C. McDowell (1977) and Leo,
McLoughlin, and Malone (1990) suggested that when polymers
are heated at temperatures above 100 C the alginate structuremay
depolymerise. McDowell (1977) also indicated that at extreme
temperatures in excess of 200 C complete breakdown of the
alginate and a rapid evolution of CO2 from the uronic acid groups
occurs. If these changes occurred during the cooking process the
alginates may not retain their inhibitory properties in the upper GI
tract. The aim of the current study was to assess whether alginate
incorporated into bread retained its viscosity and inhibitory prop-
erties after baking. The study used a model gut to digest alginate-
enriched bread and assess the physiochemical properties of the
digesta and to determine if isolated alginate retained its inhibitory
properties.
2. Methods
2.1. Materials
Sepharose 2B, methyl orange (MO), dextran blue (DB), sodium
chloride, sodium azide, Tris, methanol, acetone, colipase from
porcine pancreas  95% protein (Prod No: C3028), lipase from
porcine pancreas type II 100e500 units/mg protein using olive oil
as a substrate (Product No: L3126) and orlistat (tetrahydrolipstatin)
were purchased from SigmaeAldrich (Poole, UK). Aluminium oxide
was purchased from Fisher Scientific (Loughborough, UK), and olive
oil was purchased from Co-operative Foods (Manchester, UK).
Deoxycholic acid sodium salt and taurodeoxycholic acid sodium
salt were purchased from Fluka (Buchs, Switzerland). Alginates LFR
5/60 which is a low viscosity and low molecular weight (40,000)
sodium alginate rich in guluronate Fg 0.64, SF200 which is a high
viscosity and highmolecular weight (380,000) sodium alginate rich
in guluronate Fg 0.69 and Manucol® DM which is a high viscosity
sodium alginate with a molecular weight ranging from 250,000 to
320,000 were a gift from FMC BioPolymer AS, Drammen, Norway
and were stored at 4 C in tightly-sealed containers and all alginate
weights were corrected for water content. The control bread (CB)
and alginate bread (AB) were produced by Greggs Plc and in-
gredients are presented in Table 1. The AB was 4% alginate MAN-
UCOL®DM (w/w) wet dough as this made themost palatable bread.
2.2. Model gut procedure
The model gut replicates digestion in the mouth, stomach and
the duodenum, which is consistent with criteria set out by
Wickham, Faulks, and Mills (2009). In summary 5.2 g of the alginatebread (AB) and control bread (CB) were broken into crumbs ranging
between 2 and 4 cm as this amount of bread and conditions that
simulates the amount of bread consumed in an individual bite and
mastication in themouth. Samples were then placed into water bath
two and mixed at 75 revolutions (rpm)/min for 30 s 50 ml of syn-
thetic gastric juice was added to each sample and mixing continued
for 60 min. Following this 25 ml of porcine bile was added and
synthetic pancreatic juice was pumped in whilst mixing continued
for an additional 120min.Water baths, enzymes, synthetic solutions
and bile were all added fresh and were set at 37 C throughout the
whole process. To ensure themodel gut was replicating the pH of in-
vivo digestion the pH was monitored throughout the process as
previously described (Houghton et al., 2014).
The following experiments carried out:
i) 5.2 g Alginate bread (AB)
ii) 5.2 g Control bread (CB)
iii) 208 mg of MANUCOL DM alginate
iv) 5.2 g CB and 208 mg MANUCOL DM alginate
Model gut solution alone from 180 minwas used as a control for
all samples. 208 mg of alginate was used as this represents the total
amount of alginate contained in 5.2 g of AB.
2.3. Viscosity measurements
Samples ieiv were added at the start of the model gut and the
solutions were removed at the end of the model gut (180 min).
Samples v was model gut solution from 180 min with 208 mg of
Manucol® DM and sample vi was the same solution taken from
condition ii from 180minwith 208mg of Manucol® DM. In samples
v and vi the alginate was added upon completion of the model gut
procedure. All conditions were compared with model gut solution
alone as a control. The heated alginates were measured at 2 mg/ml
in distilled H2O, compared to distilled H2O alone.
Viscosity was measured using a Contraves low shear 30 viscom-
eter at room temperature over the speed range of 102e102min1, as
previously described (Pearson & Roberts, 2001). Results were
expressed as specific viscosity (without units as it was derived from
viscosity of the sample divided by the viscosity of the solvent).
2.4. Heating of alginate
5 g of three sodium alginates (LFR 5/60, DM and SF200) with a
molecular weight range of 40e380 kDa and a mannur-
onate:guluronate ratio of 0.44e1.38:1were heated in pyrex tubes at
37, 100 and 200 C for 30 min before being cooled to room
D. Houghton et al. / Food Hydrocolloids 49 (2015) 18e2420temperature. DM alginate was also heated at 50 and 150 C. These
alginates were selected to observe the effects on alginates ranging
in molecular weight and M and G content.
2.5. Freeze dried isolated alginate
Upon completion of the model gut incubation procedure
(180 min) the solutions from 5.2 g AB, 5.2 g CB and 5.2 g CB with
208 mg MANUCOL DM alginate (i, ii and iv) were treated as follows.
4ml and8ml samples of the5.2 gABand5.2 gCB runswere prepared
and a 4 ml sample of the 5.2 g CB with 208 mg DM alginate. All five
sampleswere diluted by 50%withmethanol,mixed and left at20 C
for 30 min. The samples were then centrifuged at 4100 rpm for
20 min. The methanol was evaporated and the remnants were
collectedand theextraction repeatedwitha further 4mlofmethanol.
The supernatants were combined and then freeze dried. The pellets
for each sample were then weighed and the recovery of alginate
calculated from the predicted alginate weight of each sample.
2.6. Gel filtration
A Sepharose 2B column 30 cm  1.5 cmwas eluted with sodium
chloride (0.2 M) and sodium azide (0.003 M) at room temperature.
1 ml of each samples at a concentration of 1.43 mg/ml in elution
buffer were loaded and 35 two ml fractions were collected. The
samples subjected to gel filtration analysis were sodium alginates
LFR 5/60, DM and SF200 post heating at 37, 100 and 200 C. The
freeze dried samples from themodel gut, 5.2 g AB, 5.2 g CB and 5.2 g
CBwith 208mg DM. 200 ml of each fractionwere added to a 96-well
plate in duplicate and the PAS assay was run as previously
described (Houghton et al., 2014).
2.7. Lipase inhibition properties of heated samples and isolated
alginate
This used the modified method of Vogel and Zieve (1961) and
Wilcox et al. (2014). Orlistat 0.025 mg/ml in DH2O was used as an
inhibition control. Heated DM alginate at 37, 100, 150 and 200 C
and freeze dried 5.2 g AB from the model gut were added to the
substrate solution at 3 and 2mg/ml and 3 and 2mg/ml respectively.
To calculate the level of inhibition the following equation was
used:Percent of lipase inhibition ¼ 1 Inhibition Control Polymer Sample
Inhibition Control Lipase Control  1002.8. Statistical analysis
Statistical calculations used SPSS Statistics 19 (IBM, Predictive
Analysis Software, USA). Data presented as mean and standard er-
ror of mean (S.E.M). A Two-way Repeated ANOVA followed by a
Post-Hoc Bonferroni were undertaken at a significant level (a) of
0.05 to compare the level of pancreatic lipase inhibition of DM
alginate heated at 37, 100, 150 and 200 C.
3. Results
3.1. Viscosity of model gut samples
The viscosities of the samples from the model gut are shown in
Fig. 1. The specific viscosity of the control bread solution afterpassing through the model gut (t ¼ 180 min) was low 0.11 ± 0.01 as
expected the viscosity of the alginate bread at t ¼ 180 min was
higher by a factor of 4 (0.42 ± 0.01). DM alginate added at time zero,
at the concentration as would be released from the alginate bread
at 180 min had a higher viscosity than the alginate bread i.e.
0.91 ± 0.41. Control bread with DM alginate added at time zero had
a viscosity of 0.46 ± 0.11 similar to that for alginate bread. These
data suggest that when bread is present there is a reduction in the
ability of alginate to form a viscous solution. The viscosity of DM
alginate added to model gut solution at the end of the procedure
(t ¼ 180) was 2.96 ± 0.71 and the viscosity of DM alginate added to
the control bread that had passed through the model gut was
2.88 ± 0.57. These results demonstrate that alginate passing
through the model, either in a bread vehicle or free had a lower
specific viscosity than if added to solution from the model gut once
it has finished. The combination of the bread andmodel gut process
attenuates the ability of the alginate to form a viscous solution.
3.2. Viscosity of heat treated alginate
The data presented in Table 2 is for alginates LFR 5/60, DM and
SF200 at 37 C and post heating at 200 C. The specific viscosity
relates to the molecular weight with SF200 having a specific vis-
cosity of 14, DM alginate 12 and LFR 5/60 2.2. Post heating at 200 C
there was an almost complete loss of viscosity. These data indicate
extensive fragmentation of the alginate chains following heating at
200 C.
The hsp for heated DM alginate is illustrated in Fig. 2. The hsp
remained relatively stable between 37, 50 and 100 C, with only a
reduction of 16 and 21% for 50 and 100 C. Beyond 100 C there is a
large drop in hsp. The hsp for 150 and 200 C was 2.2 and 0.2
respectively, equating to a reduction of 78 and 99%. The data in
Fig. 2 indicate exposure to high temperatures alter the ability of
alginate to form viscous solutions.
3.3. Freeze dried samples isolated from the end of the model gut
The alginate fraction isolated from the model gut solution at the
end of processing alginate bread in the model gut had a major PAS
positive peak eluting at the excluded volume, where DM alginate
elutes there is a tail of material stretching into the included volume
(Fig. 3). The control bread with an alginate spike at time zero, had amajor peak at the excluded volume with a second substantial peak
in the included volume. Control bread alone had a small excluded
peak and a peak in the included volume in a similar position (i.e.
fraction 20) to the included peak of the control bread spiked with
alginate. These results indicate that even after cooking alginate
bread retains high molecular weight alginate.
3.4. Lipase inhibition by isolated and heated alginate
The alginate extract from the end of the model gut was re-
suspended in substrate solution to ascertain whether the alginate
is able to retain its inhibition properties post cooking into the bread,
digestion and isolation. The freeze dried extracts from 5.2 g AB
inhibited pancreatic lipase by 39 (±0.42) and 36 (±0.43) at 3 and
2 mg/ml respectively (Fig. 4). These data indicate that although the
Fig. 1. Mean (þS.E.M.) viscosity of samples taken from the end of the model gut t ¼ 180. Alginate Bread (5.2 g), Control Bread (5.2 g), DM alginate (208 mg) and 5.2 g CB with DM
alginate (208 mg) were added at beginning of model gut. DM alginate (208 mg) was added to model gut solution and 5.2 g CB solution from the end of the model gut. GMS is gut
model solution (n ¼ 6).
Table 2
Mean (±S.E.M.) specific viscosity of alginates at 2 mg/ml in DH2O at 37 C and post heating at 200 C for 30 min (n ¼ 6).
Alginate Molecular weight Pre heating 37 C Post heating at 200 C % D in hsp
DM 250,000e320,000 12.0 (0.25) 0.1 (0.07) 99.6
LFR 5/60 40,000 2.2 (0.19) 0.2 (0.01) 90.1
SF200 380,000 14.0 (0.08) 0.2 (0.01) 98.9
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and isolated it retains inhibition properties.
Heated DM alginate at 3 and 2 mg/ml inhibits pancreatic lipase.
These data indicate that there is a significant effect for concentra-
tion and temperature (p < 0.05). The level of inhibition for 37 C
was 33% (±0.58) and 18% (±0.57), 100 C was 35 (±0.64) and 21%
(±1.46) and 150 C was 35% (±0.32) and 18% (±0.55) for 3 and 2mg/
ml respectively. The ability to inhibit lipase was all but abolished by
heating to 200 C with 4% (±0.48) and 1% (±0.26) for 3 and 2mg/ml
respectively when heated at 200 C. There was no significant dif-
ference between temperatures 37, 100 and 150 C for matched
concentrations at 3 and 2mg/ml (p > 0.05). The DM alginate heated
at 200 C was significantly different from temperatures 37, 100 and
150 C at concentration 3 and 2 mg/ml (p < 0.05). The data in Fig. 5
indicate that DM alginate is able to inhibit pancreatic lipase despite
being heated at 150 C.Fig. 2. Mean (±S.E.M.) hsp of DM alginate after being heated at 37, 50, 100, 150 and
200 C for 30 min. Each sample was then allowed to return to room temperature and
then re-suspended in DH2O at 1.43 mg/ml (n ¼ 6).4. Discussion
The ability of alginates to form both acidic and ionic gels may be
responsible for poor mixing within the stomach and small intes-
tine, and ultimately this will interfere with the ability of digestive
enzymes to interact with substrates and attenuate nutrient diges-
tion (Georg Jensen, Kristensen, Belza, Knudsen, & Astrup, 2012;
Smidsrod, 1974). Paxman, Richardson, Dettmar, and Corfe (2008)Fig. 3. Mean (±S.E.M.)- ¼ elution profile from freeze dried 5.2 g AB,: ¼ 5.2 g CB,
C ¼ 5.2 g CB and 208 mg andA ¼ 208 mg DM alginate alone from the end of model
gut and isolated process. Freeze dried samples were then re-suspended in DH2O at
1.43 mg/ml based on the freeze dried weight and processed through the gel filtration
using Sepharose 2B. PAS assay was used to quantify alginate in fractions collected from
gel filtration. Vertical axis 1 is for AB and vertical axis 2 is for CB alone and CB with DM
alginate (n ¼ 6). Vo and Vt from calibration are identified with fractions 8 and 32 using
dextran blue and methyl orange respectively (n ¼ 6).
Fig. 4. Mean (±S.E.M.) pancreatic lipase inhibition with isolated alginate from end of
the model gut and following freeze drying. Freeze dried AB were re-suspended in
lipase buffer at 3 and 2 mg/ml and the olive oil turbidity assay was run (n ¼ 9).
D. Houghton et al. / Food Hydrocolloids 49 (2015) 18e2422and Hoad et al. (2004) stated that if the alginate forms a viscous
solution/gel in the stomach this may cause distension within the
stomach and increase satiety, and therefore reduce the number of
calories an individual may consume. This was evident in previous
research that have used alginate in a beverage and shown that
alginate can modulate fat metabolism (Sandberg et al., 1994),
however we have used a cooked product and needed to ascertain if
the cooking process effected alginate properties.
Previously presented data has indicated that when AB is
digested between 10 and 15% of alginate is released in the stomach
with the remaining 85e90% released in the small intestine
(Houghton et al., 2014). Therefore it seems reasonable to assume
that if all the alginate is in fact being released, then the viscosity of
the solution at the end of the model gut should increase. However
there is not a substantial increase in viscosity from the digested AB.
A specific viscosity of 0.42 ± 0.01 is much lower than the viscosity
that would be expected for a similar concentration of alginate i.e.
8e10 in distilled water pH 7.0 for 1.43 mg/ml DM alginate. For this
reason alginate was added at the start of the model gut alone and at
the end to see if the model gut had any effect on viscosity. AlginateFig. 5. Mean (±S.E.M.) pancreatic lipase inhibition using DM alginate after it has been heat
alginate was then re-suspended in lipase substrate solution at 3 and 2 mg/ml and the turb
temperatures 37, 100, 150 and 200 C at 3 and 2 mg/ml.added to the start of the model gut and processed through the
model gut had a viscosity about twice that of the alginate released
from the bread. This was only about 1/3 of the viscosity generated
by alginate added at the end of the model gut T ¼ 180. These data
suggest that the alginate may be degraded or be binding to other
components within the model gut (Adiotomre, Eastwood, Edwards,
& Brydon, 1990; Wang, Onnagawa, Yoshie, & Suzuki, 2001). An
explanation for the drop in viscosity is pH dependent degradation.
In the gastric phase of digestion the pH falls to around 2 and proton
catalysed hydrolysis can occur (Draget, 2000, chap. 29). In addition
commercial alginate can contain small amounts of phenolic com-
pounds which can catalyse oxidative-reductive depolymerisation
(Draget, 2000, chap. 29). In fact subjection of alginate in DH2O to
the changes in pH for the same time course as the model gut results
in a fall in viscosity from 9.9 to 2.8. Any further loss of viscosity can
be attributed to hyperosmolarity in the model gut reducing the
hydrodynamic size of the alginate and fragmentation caused by
cooking. A further possibility is an interaction between alginate and
bile acids reducing viscosity. Wang et al. (2001) reported that both
the soluble and insoluble forms of dietary fibre from seaweeds
were able to bind bile acids, although soluble dietary fibres were
significantly better. This explanation is unlikely because the final
viscosity of alginate processed through themodel gut was the same
if pig bile was included or omitted (data not presented). It cannot be
ruled out that some interaction is taking place between the bread
components and alginate. This could explain the 50% difference in
viscosity between DM alginate processed through the model gut
and processed through with control bread.
During the cooking process the bread may be subject to tem-
peratures up to 200 C for 30 min. Although the exact temperature
of the entire loaf of bread here cannot be determined, Hasatani et al.
(1991) observed the effects of various bread recipes and measured
the temperature of different parts of the bread. They indicated that
the centre of the breadmay only reach 70e80 C, however the crust
may be exposed to between 180 and 200 C. It was apparent that
there is a substantial loss in viscosity ranging between 92 and 98%
when alginate is exposed to 200 C. In contrast temperatures up to
100 C had little effect. Suggesting that alginate towards the centre
of the bread would be unaffected and that in the crust fragmented
resulting in amixture of different size alginates being released from
the bread on digestion. These data are in agreement with the worked at 37, 50, 150 and 200 C for 30 min. After being left at room temperature the DM
idity assay was performed (n ¼ 9). *Denotes a significant difference (<0.05), between
D. Houghton et al. / Food Hydrocolloids 49 (2015) 18e24 23of McDowell (1977) who demonstrated that as alginates in solution
are exposed to temperatures above 100 C a gradual depolymer-
isation occurs until complete breakdown of the polymer. This
breaking down of the polymer may account for the reduction or
complete lack of viscosity as reported here. Larger alginates have a
larger Young's modulus (Smidsrod, 1974), meaning they can form
viscous gels. Consequently if the size of the alginate is being
reduced during the cooking process then this will impact upon the
alginate's ability for form a gel. This size change was confirmed by
gel filtration (data not shown). An additional point of interest may
be the molecular composition of the alginate used. There is
currently no research comparing the heat stability of a range of
alginates varying in gluronate:gluronate (GG) residues, mannur-
onate:mannuronate (MM) residues and a mixture of glur-
onate:mannuronate (GM) residue blocks. It is well known that the
properties of GG blocks are different fromGM andMM blocks in gel
formation. This therefore raises the question as to whether algi-
nates with a larger GG content are more or less heat stable than a
combination of MG andMM blocks. If the alginate is affected by the
heating during the cooking process then the isolated alginate from
the digested alginate bread would have a reduced hydrodynamic
size on gel filtration. However the majority of the released alginate
was excluded on the column indicating it was still relatively large. A
longer columnwould have allowed a better analysis of the excluded
material to see if it contained several different sized species as a
result of limited degradation. It appears that the bread matrix is
protecting the alginate from the high temperatures or the tem-
perature is not that high inside the bread.
If the alginate cooked into the bread is able towithstand cooking
and digestion then it would appear that the bread may indeed be a
suitable vehicle to add alginate to an individual's diet. Despite being
robust to withstand these processes the question remains as to
whether the alginate retains its inhibition properties once cooked
into the bread, despite the reported reduction of viscosity. Wilcox
et al. (2014) and Richardson, Dettmar, Wilcox, Brownlee, and
Pearson (2011) have reported that certain alginates are able to
reduce the activity of pancreatic lipase by up to 75%, which is
dependent on the structure of the alginate. The method used here
relies on a turbidity assay using olive oil as a substrate. This assay
has been extensively validated and gives comparable results to a
lipase activity assay using 1,2, Di-o-lauryl-rac-glycero-3-(glutaric
acid 6-methyl resorufin ester) (DGGR) as a synthetic substrate
(Wilcox et al., 2014). In addition the activity of the lipase is quoted
by the manufacture against olive oil. The data from the present
study reveals that DM alginate retains its inhibition properties after
being cooked, digested, isolated or heated at 150 C. These data not
only support the work of Asp (1987) but also demonstrates the
robustness of alginate after being processed in the various methods
described here. There was no significant difference at temperatures
37, 100 and 150 C at matched concentrations for lipase inhibition
despite the reduction in viscosity at these temperatures particularly
at 150 C. Upon exposing the alginate to 200 C the alginate
appeared to lose 88% of its inhibition properties. The data presented
here in accordance with previous work indicates that alginates
undergo depolymerisation when exposed to temperatures above
100 C, which has a profound detrimental impact upon gel for-
mation. Interestingly, when exposed to 150 C the Manucol® DM
alginate lost 78% of its hsp when compared with 37 C, however
there was no such reduction when observing the effect of heat on
alginates ability to inhibit pancreatic lipase activity. Conversely
there was a reduction of 98 and 88% for hsp and pancreatic lipase
inhibition respectively, when exposed to 200 C. These data suggest
that there is substantial alteration in polymer structure at tem-
peratures beyond 150 C which is essential for gel formation
(Braccini & Perez, 2001; Draget, Stokke, Yuguchi, Urakawa, &Kajiwara, 2003), and inhibition properties (Richardson et al.,
2011; Strugala et al., 2005; Wilcox et al., 2014). There is little data
on other fibres enclosed in a food matrix and their ability to inhibit
pancreatic lipase. However there is evidence that other fibres have
lipase inhibition properties, such as pectins (Isaksson, Lundquist, &
Ihse, 1982) and chitosan (Han, Kimura, & Okuda, 1999).
There is evidence to suggest that viscosity may play a crucial
role in the reduction of enzyme activity (Seal & Mathers, 2001;
Shah, Mahoney, & Pellett, 1986), however the data here suggests
that this is not the case for lipase inhibition. There are other
mechanismswhichmay also play a role including substrate binding
(Strugala et al., 2005;Wilcox et al., 2014). The data presented shows
alginates with a low hsp, are still able to inhibit pancreatic lipase
activity by up to 38%. The mechanism/s of how alginate inhibits
pancreatic lipase is at present not elucidated but it could be like in
pectins which are believed to protonate the active site serine and
histidine residues (Kumar & Chauhan, 2010). Although this data is
positive the question remains as to whether the AB will be able to
inhibit pancreatic lipase in-vivo. The turbidity assay used here was
adapted from Vogel and Zieve (1961) and works on the basis that as
the fat is digested the substrate solution becomes more trans-
parent. Although this is an effective method for determining
pancreatic lipase activity, this does not however take into account
other factors within the in vivo gut such as bile, undigested bread
and the plethora of other enzymes involved in digestion. Further
work is required to ascertain whether the lack of viscosity reported
here has any impact upon the ability of AB to inhibit, fat digestion
in-vivo. In conclusion the present study demonstrates that alginates
are heat stable up to temperatures of 100 C. However beyond
100 C there is a gradual decrease in viscosity as the temperature
increases. By contrast the ability of the alginate to inhibit pancreatic
lipase appears to be unaffected up to temperatures of 150 C,
despite the reduction in viscosity and by implication size.
Furthermore, despite being used as an additive to a bread vehicle,
cooked, digested in a model gut and isolated the alginate retains its
inhibition properties and does not appear to be affected by these
processes.Acknowledgements
The authors' contributions are as follows D.H designed the
study, C.J.S and J.P.P supervised the study and M.D.W, P.I.C and I.A.B
provided support and guidance. All authors contributed to writing
and revising the paper. All authors had access to the data and were
accountable for the integrity of the data and accuracy of data
analysis. D.H was the principal investigator and drafted the
manuscript. D.H was the guarantor for the contents of the paper.
The full protocol may be obtained from D.H. There are no conflicts
of interest. This studywas funded as part of a PhD by the BBSRC Diet
and Health Research Industry Club (BBG530084/1).References
Adiotomre, J., Eastwood, M. A., Edwards, C. A., & Brydon, W. G. (1990). Dietary fiber:
in vitro methods that anticipate nutrition and metabolic activity in humans.
American Journal of Clinical Nutrition, 52(1), 128e134.
Asp, N. G. (1987). Definition and analysis of dietary fibre. Scandinavian Journal of
Gastroenterology e Supplement, 129, 16e20.
Ayyad, C., & Andersen, T. (2000). Long-term efficacy of dietary treatment of obesity:
a systematic review of studies published between 1931 and 1999 [Review]
Obesity Reviews, 1(2), 113e119.
Braccini, I., & Perez, S. (2001). Molecular basis of C(2þ)-induced gelation in algi-
nates and pectins: the egg-box model revisited [Research support, non-U.S.
Gov't] Biomacromolecules, 2(4), 1089e1096.
Brownlee, I. A., Allen, A., Pearson, J. P., Dettmar, P. W., Havler, M. E., Atherton, M. R.,
et al. (2005). Alginate as a source of dietary fiber [Review] Critical Reviews in
Food Science & Nutrition, 45(6), 497e510.
D. Houghton et al. / Food Hydrocolloids 49 (2015) 18e2424Draget, K. I. (2000). In G. O. Phillips, & P. A. Williams (Eds.), Handbook of hydro-
colloids (2nd ed.). (pp. 807e825). Cambridge: Woodhead Publishing Limited.
Draget, K. I., Skjåk Bræka, G., & Stokke, B. T. (2005). Similarities and differences
between alginic acid gels and ionically crosslinked alginate gels. Food Hydro-
colloids, 20(2e3), 170e175.
Draget, K. I., Stokke, B. T., Yuguchi, Y., Urakawa, H., & Kajiwara, K. (2003). Small-
angle X-ray scattering and rheological characterization of alginate gels. 3.
Alginic acid gels [Research support, non-U.S. Gov't] Biomacromolecules, 4(6),
1661e1668.
Ellis, P. R., Apling, E. C., Leeds, A. R., & Bolster, N. R. (1981). Guar bread: acceptability
and efficacy combined. Studies on blood glucose, serum insulin and satiety in
normal subjects. British Journal of Nutrition, 46(2), 267e276.
FAO/WHO. (2003). Report of the fourth session of the codex ad hoc intergovern-
mental task force on foods derived from biotechnology. From http://
codexalimentarius.net/web/archives.jsp?year¼09.
Finer, N., James, W. P., Kopelman, P. G., Lean, M. E., & Williams, G. (2000). One-year
treatment of obesity: a randomized, double-blind, placebo-controlled, multi-
centre study of orlistat, a gastrointestinal lipase inhibitor. International Journal
of Obesity & Related Metabolic Disorders: Journal of the International Association
for the Study of Obesity, 24(3), 306e313.
Georg Jensen, M., Kristensen, M., & Astrup, A. (2012). Effect of alginate supple-
mentation on weight loss in obese subjects completing a 12-wk energy-
restricted diet: a randomized controlled trial. American Journal of Clinical
Nutrition, 96(1), 5e13.
Georg Jensen, M., Kristensen, M., Belza, A., Knudsen, J. C., & Astrup, A. (2012). Acute
effect of alginate-based preload on satiety feelings, energy intake, and gastric
emptying rate in healthy subjects. Obesity, 20(9), 1851e1858.
Grasdalen, H. B., Larsen, O., & Smidsrod, O. (1977). C-13-NMR studies of alginates.
Carbohydrate Research, 56(2), 11e15.
Hadvary, P., Lengsfeld, H., & Wolfer, H. (1988). Inhibition of pancreatic lipase in vitro
by the covalent inhibitor tetrahydrolipstatin. Biochemistry Journal, 256(2),
357e361.
Han, L. K., Kimura, Y., & Okuda, H. (1999). Reduction in fat storage during chitin-
chitosan treatment in mice fed a high-fat diet [Research support, non-U.S.
Gov't] International Journal of Obesity and Related Metabolic Disorders, 23(2),
174e179.
Hasatani, M., Arai, N., Katsuyama, H., Harui, H., Itaya, Y., Fushida, N., et al. (1991).
Heat and mass transfer in bread during baking in an electric oven. In Drying, 91.
Hoad, C. L., Rayment, P., Spiller, R. C., Marciani, L., Alonso Bde, C., Traynor, C., et al.
(2004). In vivo imaging of intragastric gelation and its effect on satiety in
humans. Journal of Nutrition, 134(9), 2293e2300.
Houghton, D., Wilcox, M. D., Brownlee, I. A., Chater, P., Seal, C. J., & Pearson, J. P.
(2014). Method for quantifying alginate and determining release from a food
vehicle in gastrointestinal digesta. Food Chemistry, 151, 352e357. http://
dx.doi.org/10.1016/j.foodchem.2013.11.070.
Isaksson, G., Lundquist, I., & Ihse, I. (1982). In vitro inhibition of pancreatic enzyme
activities by dietary fiber. Digestion, 24(1), 54e59.
Kumar, A., & Chauhan, G. S. (2010). Extraction and characterization of pectin from
apple pomace and its evaluation as lipase (steapsin) inhibitor. Carbohydrate
Polymers, 82(2), 454e459.
Leo, W. J., McLoughlin, A. J., & Malone, D. M. (1990). Effects of sterilization treat-
ments on some properties of alginate solutions and gels [Comparative study]
Biotechnology Progress, 6(1), 51e53.
McDowell, R. H. (1977). Properties of alginates. London: Alginate Industries.
Paxman, J. R., Richardson, J. C., Dettmar, P. W., & Corfe, B. M. (2008). Daily ingestion
of alginate reduces energy intake in free-living subjects. Appetite, 51(3),
713e719.Pearson, J. P., & Roberts, N. B. (2001). Mucosal protective effects of ecabet sodium:
pepsin inhibition and interaction with mucus. Clinical Science, 100(4), 411e417.
Pi-Sunyer, F. X. (2006). Use of lifestyle changes treatment plans and drug therapy in
controlling cardiovascular and metabolic risk factors [Review] Obesity,
14(Suppl. 3), 135Se142S.
Rich, S., Rubin, L., Walker, A. M., Schneeweiss, S., & Abenhaim, L. (2000). Ano-
rexigens and pulmonary hypertension in the United States: results from the
surveillance of North American pulmonary hypertension. Chest, 117(3),
870e874.
Richardson, J. C., Dettmar, P. W., Wilcox, M. D., Brownlee, I. A., & Pearson, J. P. (2011).
UK Patent No. University of Newcastle upon Tyne.
Sandberg, A. S., Andersson, H., Bosaeus, I., Carlsson, N. G., Hasselblad, K., &
Harrod, M. (1994). Alginate, small bowel sterol excretion, and absorption of
nutrients in ileostomy subjects. American Journal of Clinical Nutrition, 60(5),
751e756.
Seal, C. J., & Mathers, J. C. (2001). Comparative gastrointestinal and plasma
cholesterol responses of rats fed on cholesterol-free diets supplemented with
guar gum and sodium alginate [Comparative study] British Journal of Nutrition,
85(3), 317e324.
Shah, N., Mahoney, R. R., & Pellett, P. L. (1986). Effect of guar gum, lignin and pectin
on proteolytic enzyme levels in the gastrointestinal tract of the rat: a time-
based study [Research support, non-U.S. Gov't] Journal of Nutrition, 116(5),
786e794.
Smidsrod, O. (1974). Molecular basis for some physical properties of alginates in the
gel state. Faraday Discussions, 57, 263e274.
Strugala, V., Kennington, E. J., Campbell, R. J., Skjak-Braek, G., & Dettmar, P. W.
(2005). Inhibition of pepsin activity by alginates in vitro and the effect of epi-
merization [Research support, non-U.S. Gov't] International Journal of Pharma-
ceutics, 304(1e2), 40e50.
Sunderland, A. M., Dettmar, P. W., & Pearson, J. P. (2000). Alginates inhibit pepsin
activity in vitro: a justification for their use in gastro-oesophageal reflux disease
(GORD). Gastroenterology, 118(4).
Torsdottir, I., Alpsten, M., Holm, G., Sandberg, A. S., & Tolli, J. (1991). A small dose of
soluble alginate-fiber affects postprandial glycemia and gastric emptying in
humans with diabetes. Journal of Nutrition, 121(6), 795e799.
Vogel, W. C., & Zieve, L. (1961). A rapid and sensitive turbidimetric method for
serum lipase based upon differences between the lipase of normal and
pancreatitis serum. Clinical Chemistry, 9(2), 168e181.
Wang, W., Onnagawa, M., Yoshie, Y., & Suzuki, T. (2001). Binding of bile salts to
soluble and insoluble dietary fibers of seaweeds. Fisheries Science, 67(6),
1169e1173.
Wickham, M., Faulks, R., & Mills, C. (2009). In vitro digestion methods for assessing
the effect of food structure on allergen breakdown. Molecular Nutrition & Food
Research, 53(8), 952e958. http://dx.doi.org/10.1002/mnfr.200800193.
Wilcox, M., Brownlee, I. A., Richardson, J. C., Dettmar, P. W., & Pearson, J. P. (2014).
The modulation of pancreatic lipase activity by alginates [Research support,
non-U.S. Gov't] Food Chemistry, 146, 479e484. http://dx.doi.org/10.1016/
j.foodchem.2013.09.075.
Williams, J. A., Lai, C. S., Corwin, H., Ma, Y., Maki, K. C., Garleb, K. A., et al. (2004).
Inclusion of guar gum and alginate into a crispy bar improves postprandial
glycemia in humans. Journal of Nutrition, 134(4), 886e889.
Wolf, B. W., Lai, C. S., Kipnes, M. S., Ataya, D. G., Wheeler, K. B., Zinker, B. A., et al.
(2002). Glycemic and insulinemic responses of nondiabetic healthy adult sub-
jects to an experimental acid-induced viscosity complex incorporated into a
glucose beverage. Nutrition, 18(7e8), 621e626.
